CompletedNot Applicable

SSC-COVID in Patients After COVID-19

Germany64 participantsStarted 2020-03-01

Plain-language summary

Analysis of occurrence of SSC-COVID in SARS-CoV-2-patients after the first wave of COVID-pandemic

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * post-COVID19-patients with required hospitalization during the first wave of COVID-19-pandemic * patients controlled at the university ambulance for follow-up Exclusion Criteria: * children and patients younger than 18 years

What they're measuring

Incidence of SSC-COVID in hospitalized COVID-patients of the first wave

Timeframe: one and a half year

Trial details

NCT IDNCT05233553

SponsorUniversity Hospital Tuebingen

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-31

View on ClinicalTrials.gov More Secondary Sclerosing Cholangitis trials